sulfadoxine has been researched along with 2019 Novel Coronavirus Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Amone, J; Dall'Oglio, G; De Vita, E; Di Gennaro, F; Fantoni, M; Iacobelli, V; Ictho, J; L'Episcopia, M; Lochoro, P; Marotta, C; Murri, R; Ngole, B; Ogwang, J; Okori, S; Olal, L; Onapa, E; Putoto, G; Saracino, A; Segala, FV; Severini, C | 1 |
Arya, A; Chaudhry, S; Foko, LPK; Hawadak, J; Kumar, A; Nana, RRD; Singh, V | 1 |
Boncy, J; Chang, MA; Fouché, B; Gaul, DA; Green, M; Holmes, K; Juin, S; Kheradmand, T; LaFortune, W; Marseille, S; Moore, SG; Rigodon, J; Rogier, E; Telfort, MA | 1 |
1 review(s) available for sulfadoxine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Intermittent preventive treatment with Sulfadoxine pyrimethamine for malaria: a global overview and challenges affecting optimal drug uptake in pregnant women.
Topics: Antimalarials; COVID-19; Drug Combinations; Female; Humans; Malaria; Pharmaceutical Preparations; Pregnancy; Pregnancy Complications, Parasitic; Pregnant Women; Pyrimethamine; Sulfadoxine | 2023 |
2 other study(ies) available for sulfadoxine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Impact of antimalarial resistance and COVID-19 pandemic on malaria care among pregnant women in Northern Uganda (ERASE): protocol of a prospective observational study.
Topics: Antimalarials; Artemisinins; COVID-19; Drug Combinations; Drug Resistance; Female; Humans; Malaria, Falciparum; Observational Studies as Topic; Pandemics; Pregnancy; Pregnant Women; Prospective Studies; Pyrimethamine; Retrospective Studies; Sulfadoxine; Uganda | 2022 |
Investigation of Four Cases of Stevens-Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020.
Topics: Antimalarials; COVID-19; Drug Combinations; Haiti; Humans; Malaria; Mass Drug Administration; Pandemics; Primaquine; Pyrimethamine; SARS-CoV-2; Stevens-Johnson Syndrome; Sulfadoxine | 2023 |